Ryu Han Suk, Lee Seung-Sook, Choi Hee-Seung, Baek Heejong, Koh Jae Soo
Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea.
Diagn Cytopathol. 2011 Nov;39(11):801-7. doi: 10.1002/dc.21463. Epub 2010 Nov 2.
Malignant epithelioid hemangioendothelioma (MEHE) is a rare vascular tumor with a biological behavior that lies between those of classical epithelioid hemangioendothelioma and angiosarcoma. Furthermore, MEHE is rarely diagnosed by fine needle aspiration cytology. The authors describe the cytological features of MEHE in a 41-year-old man who presented with increasing dyspnea over a period of 1 month before admission. Computed tomography of the chest showed a 3 cm poorly defined mass in the right lower lobe. Fine needle aspiration cytology demonstrated cellular smears of loosely cohesive clusters of epithelioid cells with numerous intracytoplasmic lumens in a necrotic background. Cellular features included fine chromatin and vesicular or slightly hyperchromatic nuclei with inconspicuous nucleoli and intranuclear inclusions. Nuclear membranes were relatively irregular with indentation. Mean N/C ratio was not increased, presumably due to a moderate amount of cytoplasm. The histologic examination displayed epithelioid and spindle cell proliferation with necrosis accompanying a classical epithelioid hemangioendotheliomatous area. The immunohistochemical evaluation was confirmatory and showed immunoreactivity for vascular markers. The authors also reviewed FNAB findings of epithelioid angiosarcoma, primary adenocarcinoma, and bronchioloalveolar carcinoma of the lung to identify cytomorphologic differences by literature bases. MEHE of the lung is difficult to diagnose cytologically because of its rarity and its cytomorphologic similarities with other malignant epithelial and mesenchymal tumors. However, it may be possible to distinguish it from other entities when the possibility of this unusual vascular neoplasm is suspected and ancillary studies are supportive.
恶性上皮样血管内皮瘤(MEHE)是一种罕见的血管肿瘤,其生物学行为介于经典上皮样血管内皮瘤和血管肉瘤之间。此外,MEHE很少通过细针穿刺细胞学检查来诊断。作者描述了一名41岁男性MEHE的细胞学特征,该患者在入院前1个月内出现进行性呼吸困难。胸部计算机断层扫描显示右下叶有一个3 cm边界不清的肿块。细针穿刺细胞学检查显示,在坏死背景下,细胞涂片可见上皮样细胞松散聚集的细胞团,有许多胞质内管腔。细胞特征包括细染色质、泡状或轻度深染的细胞核,核仁不明显,有核内包涵体。核膜相对不规则,有切迹。平均核质比未增加,可能是由于胞质含量适中。组织学检查显示上皮样和梭形细胞增生伴坏死,伴有经典的上皮样血管内皮瘤区域。免疫组织化学评估具有确诊意义,显示血管标志物呈免疫反应性。作者还回顾了肺上皮样血管肉瘤、原发性腺癌和细支气管肺泡癌的细针穿刺活检结果,以通过文献依据确定细胞形态学差异。由于其罕见性以及与其他恶性上皮和间叶性肿瘤的细胞形态学相似性,肺MEHE很难通过细胞学诊断。然而,当怀疑存在这种不寻常的血管肿瘤且辅助检查支持时,有可能将其与其他实体区分开来。